Summary

The global market for Marine Pharmaceuticals was estimated to be worth US$ 34690 million in 2024 and is forecast to a readjusted size of US$ 60920 million by 2031 with a CAGR of 8.5% during the forecast period 2025-2031.
The drug obtained from marine organisms which are being conventionally used like shark and cod-liver oils, sodium alginate, agar-agar, chitin etc. Marine organisms are potential source for drug discovery. Life has originated from the oceans that cover over 70% of the surface of earth and contain highly ecological, chemical and biological diversity starting from micro-organisms to vertebrates. This diversity has been the source of unique chemical compounds, which hold tremendous pharmaceutical potential. In our report, we study the drugs and health supplement from marine.

Marine pharmaceuticals refer to natural products with pharmacological activity derived from marine organisms, including small molecule drugs, proteins, glycosaminoglycans, and other forms. These drugs are sourced from marine organisms such as sponges, seaweeds, mollusks, and deep-sea microorganisms, possessing unique structures and biological activities, often used in the treatment of cancer, viral infections, inflammation, and other conditions. With the advancement of marine biodiversity research, marine pharmaceuticals have gradually become a significant focus in new drug development.
The marine pharmaceutical industry is in a phase of rapid development, driven by several factors. Firstly, there is an increasing global demand for new drugs, especially in areas like cancer, viral infections, and inflammation, making marine pharmaceuticals a research hotspot due to their unique biological activities. Secondly, advancements in technologies such as genomics, proteomics, and high-throughput screening have provided strong support for the discovery and development of marine drugs. Additionally, continuous investment from governments and enterprises in marine pharmaceutical research and development is accelerating industry growth.
Despite the promising prospects of the marine pharmaceutical industry, it faces several challenges and risks. Firstly, the research and development cycle for marine drugs is long, costly, and has a low clinical conversion rate, leading to a slow industrialization process. Secondly, the acquisition of marine resources is restricted by environmental protection policies, resulting in unstable resource supply. Moreover, the production processes for marine drugs are complex, and large-scale manufacturing faces both technical and cost pressures.

The downstream demand for marine pharmaceuticals is primarily concentrated in the pharmaceutical, health supplement, and cosmetics industries. With increasing public awareness of health, the demand for natural medicines and functional health products continues to grow. Marine pharmaceuticals, especially in the treatment of chronic diseases such as cancer and autoimmune disorders, are gaining attention due to their unique efficacy. Simultaneously, with the advent of an aging society, the market demand for anti-aging and anti-inflammatory marine drugs is also on the rise.
The upstream raw materials for marine pharmaceuticals mainly include marine biological resources and related biotechnological support. The diversity of marine biological resources provides abundant materials for the development of marine drugs. However, the sustainable acquisition and protection of marine resources have become critical issues. At the same time, advancements in biotechnology, such as gene editing and synthetic biology, offer new pathways for the efficient production of marine pharmaceuticals.

This report aims to provide a comprehensive presentation of the global market for Marine Pharmaceuticals, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Marine Pharmaceuticals by region & country, by Type, and by Application.
The Marine Pharmaceuticals market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Marine Pharmaceuticals.

Market Segmentation
By Company
Seattle Genetics
DSM
Eisai Co
Takeda
BASF
Amway
Pfizer
Pelagia (EPAX)
Pharma Mar
Croda
GNC
GSK
TerSera Therapeutics
Nordic Naturals
Carlson Labs
Segment by Type
Drugs
Health Supplement
Segment by Application
Hospital & Clinic
Pharmacy
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Marine Pharmaceuticals company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Marine Pharmaceuticals in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Marine Pharmaceuticals in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

ページTOPに戻る

Table of Contents

1 Market Overview
1.1 Marine Pharmaceuticals Product Introduction
1.2 Global Marine Pharmaceuticals Market Size Forecast (2020-2031)
1.3 Marine Pharmaceuticals Market Trends & Drivers
1.3.1 Marine Pharmaceuticals Industry Trends
1.3.2 Marine Pharmaceuticals Market Drivers & Opportunity
1.3.3 Marine Pharmaceuticals Market Challenges
1.3.4 Marine Pharmaceuticals Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Marine Pharmaceuticals Players Revenue Ranking (2024)
2.2 Global Marine Pharmaceuticals Revenue by Company (2020-2025)
2.3 Key Companies Marine Pharmaceuticals Manufacturing Base Distribution and Headquarters
2.4 Key Companies Marine Pharmaceuticals Product Offered
2.5 Key Companies Time to Begin Mass Production of Marine Pharmaceuticals
2.6 Marine Pharmaceuticals Market Competitive Analysis
2.6.1 Marine Pharmaceuticals Market Concentration Rate (2020-2025)
2.6.2 Global 5 and 10 Largest Companies by Marine Pharmaceuticals Revenue in 2024
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Marine Pharmaceuticals as of 2024)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Drugs
3.1.2 Health Supplement
3.2 Global Marine Pharmaceuticals Sales Value by Type
3.2.1 Global Marine Pharmaceuticals Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Marine Pharmaceuticals Sales Value, by Type (2020-2031)
3.2.3 Global Marine Pharmaceuticals Sales Value, by Type (%) (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital & Clinic
4.1.2 Pharmacy
4.1.3 Other
4.2 Global Marine Pharmaceuticals Sales Value by Application
4.2.1 Global Marine Pharmaceuticals Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Marine Pharmaceuticals Sales Value, by Application (2020-2031)
4.2.3 Global Marine Pharmaceuticals Sales Value, by Application (%) (2020-2031)
5 Segmentation by Region
5.1 Global Marine Pharmaceuticals Sales Value by Region
5.1.1 Global Marine Pharmaceuticals Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Marine Pharmaceuticals Sales Value by Region (2020-2025)
5.1.3 Global Marine Pharmaceuticals Sales Value by Region (2026-2031)
5.1.4 Global Marine Pharmaceuticals Sales Value by Region (%), (2020-2031)
5.2 North America
5.2.1 North America Marine Pharmaceuticals Sales Value, 2020-2031
5.2.2 North America Marine Pharmaceuticals Sales Value by Country (%), 2024 VS 2031
5.3 Europe
5.3.1 Europe Marine Pharmaceuticals Sales Value, 2020-2031
5.3.2 Europe Marine Pharmaceuticals Sales Value by Country (%), 2024 VS 2031
5.4 Asia Pacific
5.4.1 Asia Pacific Marine Pharmaceuticals Sales Value, 2020-2031
5.4.2 Asia Pacific Marine Pharmaceuticals Sales Value by Region (%), 2024 VS 2031
5.5 South America
5.5.1 South America Marine Pharmaceuticals Sales Value, 2020-2031
5.5.2 South America Marine Pharmaceuticals Sales Value by Country (%), 2024 VS 2031
5.6 Middle East & Africa
5.6.1 Middle East & Africa Marine Pharmaceuticals Sales Value, 2020-2031
5.6.2 Middle East & Africa Marine Pharmaceuticals Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Marine Pharmaceuticals Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Marine Pharmaceuticals Sales Value, 2020-2031
6.3 United States
6.3.1 United States Marine Pharmaceuticals Sales Value, 2020-2031
6.3.2 United States Marine Pharmaceuticals Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Marine Pharmaceuticals Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Marine Pharmaceuticals Sales Value, 2020-2031
6.4.2 Europe Marine Pharmaceuticals Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Marine Pharmaceuticals Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Marine Pharmaceuticals Sales Value, 2020-2031
6.5.2 China Marine Pharmaceuticals Sales Value by Type (%), 2024 VS 2031
6.5.3 China Marine Pharmaceuticals Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Marine Pharmaceuticals Sales Value, 2020-2031
6.6.2 Japan Marine Pharmaceuticals Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Marine Pharmaceuticals Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Marine Pharmaceuticals Sales Value, 2020-2031
6.7.2 South Korea Marine Pharmaceuticals Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Marine Pharmaceuticals Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Marine Pharmaceuticals Sales Value, 2020-2031
6.8.2 Southeast Asia Marine Pharmaceuticals Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Marine Pharmaceuticals Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Marine Pharmaceuticals Sales Value, 2020-2031
6.9.2 India Marine Pharmaceuticals Sales Value by Type (%), 2024 VS 2031
6.9.3 India Marine Pharmaceuticals Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Seattle Genetics
7.1.1 Seattle Genetics Profile
7.1.2 Seattle Genetics Main Business
7.1.3 Seattle Genetics Marine Pharmaceuticals Products, Services and Solutions
7.1.4 Seattle Genetics Marine Pharmaceuticals Revenue (US$ Million) & (2020-2025)
7.1.5 Seattle Genetics Recent Developments
7.2 DSM
7.2.1 DSM Profile
7.2.2 DSM Main Business
7.2.3 DSM Marine Pharmaceuticals Products, Services and Solutions
7.2.4 DSM Marine Pharmaceuticals Revenue (US$ Million) & (2020-2025)
7.2.5 DSM Recent Developments
7.3 Eisai Co
7.3.1 Eisai Co Profile
7.3.2 Eisai Co Main Business
7.3.3 Eisai Co Marine Pharmaceuticals Products, Services and Solutions
7.3.4 Eisai Co Marine Pharmaceuticals Revenue (US$ Million) & (2020-2025)
7.3.5 Eisai Co Recent Developments
7.4 Takeda
7.4.1 Takeda Profile
7.4.2 Takeda Main Business
7.4.3 Takeda Marine Pharmaceuticals Products, Services and Solutions
7.4.4 Takeda Marine Pharmaceuticals Revenue (US$ Million) & (2020-2025)
7.4.5 Takeda Recent Developments
7.5 BASF
7.5.1 BASF Profile
7.5.2 BASF Main Business
7.5.3 BASF Marine Pharmaceuticals Products, Services and Solutions
7.5.4 BASF Marine Pharmaceuticals Revenue (US$ Million) & (2020-2025)
7.5.5 BASF Recent Developments
7.6 Amway
7.6.1 Amway Profile
7.6.2 Amway Main Business
7.6.3 Amway Marine Pharmaceuticals Products, Services and Solutions
7.6.4 Amway Marine Pharmaceuticals Revenue (US$ Million) & (2020-2025)
7.6.5 Amway Recent Developments
7.7 Pfizer
7.7.1 Pfizer Profile
7.7.2 Pfizer Main Business
7.7.3 Pfizer Marine Pharmaceuticals Products, Services and Solutions
7.7.4 Pfizer Marine Pharmaceuticals Revenue (US$ Million) & (2020-2025)
7.7.5 Pfizer Recent Developments
7.8 Pelagia (EPAX)
7.8.1 Pelagia (EPAX) Profile
7.8.2 Pelagia (EPAX) Main Business
7.8.3 Pelagia (EPAX) Marine Pharmaceuticals Products, Services and Solutions
7.8.4 Pelagia (EPAX) Marine Pharmaceuticals Revenue (US$ Million) & (2020-2025)
7.8.5 Pelagia (EPAX) Recent Developments
7.9 Pharma Mar
7.9.1 Pharma Mar Profile
7.9.2 Pharma Mar Main Business
7.9.3 Pharma Mar Marine Pharmaceuticals Products, Services and Solutions
7.9.4 Pharma Mar Marine Pharmaceuticals Revenue (US$ Million) & (2020-2025)
7.9.5 Pharma Mar Recent Developments
7.10 Croda
7.10.1 Croda Profile
7.10.2 Croda Main Business
7.10.3 Croda Marine Pharmaceuticals Products, Services and Solutions
7.10.4 Croda Marine Pharmaceuticals Revenue (US$ Million) & (2020-2025)
7.10.5 Croda Recent Developments
7.11 GNC
7.11.1 GNC Profile
7.11.2 GNC Main Business
7.11.3 GNC Marine Pharmaceuticals Products, Services and Solutions
7.11.4 GNC Marine Pharmaceuticals Revenue (US$ Million) & (2020-2025)
7.11.5 GNC Recent Developments
7.12 GSK
7.12.1 GSK Profile
7.12.2 GSK Main Business
7.12.3 GSK Marine Pharmaceuticals Products, Services and Solutions
7.12.4 GSK Marine Pharmaceuticals Revenue (US$ Million) & (2020-2025)
7.12.5 GSK Recent Developments
7.13 TerSera Therapeutics
7.13.1 TerSera Therapeutics Profile
7.13.2 TerSera Therapeutics Main Business
7.13.3 TerSera Therapeutics Marine Pharmaceuticals Products, Services and Solutions
7.13.4 TerSera Therapeutics Marine Pharmaceuticals Revenue (US$ Million) & (2020-2025)
7.13.5 TerSera Therapeutics Recent Developments
7.14 Nordic Naturals
7.14.1 Nordic Naturals Profile
7.14.2 Nordic Naturals Main Business
7.14.3 Nordic Naturals Marine Pharmaceuticals Products, Services and Solutions
7.14.4 Nordic Naturals Marine Pharmaceuticals Revenue (US$ Million) & (2020-2025)
7.14.5 Nordic Naturals Recent Developments
7.15 Carlson Labs
7.15.1 Carlson Labs Profile
7.15.2 Carlson Labs Main Business
7.15.3 Carlson Labs Marine Pharmaceuticals Products, Services and Solutions
7.15.4 Carlson Labs Marine Pharmaceuticals Revenue (US$ Million) & (2020-2025)
7.15.5 Carlson Labs Recent Developments
8 Industry Chain Analysis
8.1 Marine Pharmaceuticals Industrial Chain
8.2 Marine Pharmaceuticals Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Marine Pharmaceuticals Sales Model
8.5.2 Sales Channel
8.5.3 Marine Pharmaceuticals Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer